Caption Management, LLC Apellis Pharmaceuticals, Inc. Transaction History
Caption Management, LLC
- $5.74 Billion
- Q3 2024
A detailed history of Caption Management, LLC transactions in Apellis Pharmaceuticals, Inc. stock. As of the latest transaction made, Caption Management, LLC holds 590,000 shares of APLS stock, worth $19.9 Million. This represents 0.3% of its overall portfolio holdings.
Number of Shares
590,000
Previous 1,004,700
41.28%
Holding current value
$19.9 Million
Previous $38.5 Million
55.85%
% of portfolio
0.3%
Previous 0.63%
Shares
11 transactions
Others Institutions Holding APLS
# of Institutions
309Shares Held
115MCall Options Held
3.85MPut Options Held
1.09M-
Wellington Management Group LLP Boston, MA15.6MShares$524 Million0.08% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA11.9MShares$400 Million14.88% of portfolio
-
Avoro Capital Advisors LLC New York, NY11.1MShares$374 Million4.82% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.82MShares$330 Million0.01% of portfolio
-
Black Rock Inc. New York, NY5.8MShares$195 Million0.01% of portfolio
About Apellis Pharmaceuticals, Inc.
- Ticker APLS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 109,865,000
- Market Cap $3.7B
- Description
- Apellis Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic compounds through the inhibition of the complement system for autoimmune and inflammatory diseases. The company's lead product candidate is pegcetacoplan that is in Phase III clinical trials for...